ATE131071T1 - Leukozyten-adhäsions-inhibitor. - Google Patents

Leukozyten-adhäsions-inhibitor.

Info

Publication number
ATE131071T1
ATE131071T1 AT89910339T AT89910339T ATE131071T1 AT E131071 T1 ATE131071 T1 AT E131071T1 AT 89910339 T AT89910339 T AT 89910339T AT 89910339 T AT89910339 T AT 89910339T AT E131071 T1 ATE131071 T1 AT E131071T1
Authority
AT
Austria
Prior art keywords
leukocyte adhesion
adhesion inhibitor
endothelial cells
endothelial
inflammation
Prior art date
Application number
AT89910339T
Other languages
English (en)
Inventor
Michael A Gimbrone Jr
Margaret Elyse Wheeler
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Application granted granted Critical
Publication of ATE131071T1 publication Critical patent/ATE131071T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89910339T 1988-08-15 1989-08-15 Leukozyten-adhäsions-inhibitor. ATE131071T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23222488A 1988-08-15 1988-08-15

Publications (1)

Publication Number Publication Date
ATE131071T1 true ATE131071T1 (de) 1995-12-15

Family

ID=22872317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89910339T ATE131071T1 (de) 1988-08-15 1989-08-15 Leukozyten-adhäsions-inhibitor.

Country Status (6)

Country Link
US (1) US5302384A (de)
EP (1) EP0429542B1 (de)
JP (1) JPH04500076A (de)
AT (1) ATE131071T1 (de)
DE (1) DE68925032T2 (de)
WO (1) WO1990001338A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATA901588A (de) 1987-11-19 1994-07-15 Sandoz Ag Von humanmonozyten abgeleiteter neutrophilenaktivierungsfaktor (naf) und verfahren zu seiner herstellung
EP0502897A4 (en) * 1989-11-29 1993-03-03 Brigham And Women's Hospital Endothelial-derived il-8
WO1991008231A1 (en) * 1989-11-29 1991-06-13 Brigham And Women's Hospital [Ala IL-8]77 AS A LEUKOCYTE ADHESION INHIBITOR
AU3078892A (en) * 1991-12-04 1993-06-28 Biomedical Research Centre Limited, The Human interleukin-8 analogs
US7135458B1 (en) * 1995-11-15 2006-11-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
US5811073A (en) * 1995-06-19 1998-09-22 President And Fellows Of Harvard College Method for radioisotopic detection and localization of inflammation in a host
DE19548630A1 (de) * 1995-12-12 1997-06-19 Schering Ag Verfahren zur Reinigung von rekombinantem Human-Interleukin - 8
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
DE10003811A1 (de) * 2000-01-28 2001-08-09 Sanorell Pharma Gmbh & Co Verfahren zur Herstellung eines serumhaltigen Kulturmediums für Zellen sowie dessen Verwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5729949A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determination of sugar branch related to cancer and diagnostic technique of cancer
US4897348A (en) * 1983-08-25 1990-01-30 Sri International Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof
ATE128727T1 (de) * 1987-05-04 1995-10-15 Dana Farber Cancer Inst Inc Interzellulare adhäsions-moleküle und deren bindungsliganden.
US4840793A (en) * 1987-06-11 1989-06-20 Dana-Farber Cancer Institute Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
US4797277A (en) * 1987-09-22 1989-01-10 Pharmacia Ab Method for reperfusion therapy
ATA901588A (de) * 1987-11-19 1994-07-15 Sandoz Ag Von humanmonozyten abgeleiteter neutrophilenaktivierungsfaktor (naf) und verfahren zu seiner herstellung

Also Published As

Publication number Publication date
EP0429542B1 (de) 1995-12-06
US5302384A (en) 1994-04-12
EP0429542A1 (de) 1991-06-05
DE68925032T2 (de) 1996-04-25
EP0429542A4 (en) 1991-12-11
DE68925032D1 (de) 1996-01-18
JPH04500076A (ja) 1992-01-09
WO1990001338A1 (en) 1990-02-22

Similar Documents

Publication Publication Date Title
DE68925032D1 (de) Leukozyten-adhäsions-inhibitor.
ATE193304T1 (de) Inhibitoren der menschlichen neutrophilenelastase
ATE140968T1 (de) Kultur des wachstumsfaktors der vaskularen endothelialzellen und dns, die dafür kodiert
FI893962A7 (fi) HIV-proteaasi-inhibiittoreita, jotka ovat hyödyllisiä AIDS:in hoidossa
FI872720A7 (fi) Neutraaliset metalliendopeptidaasi-inhibiittorit hypertension hoidossa
DE69818049D1 (de) Inhibitoren der alpha4-beta1 vermittelten zelladhäsion
FI981591L (fi) AIDS:n hoidossa käyttökelpoisia HIV-proteaasi-inhibiittoreita
FI906212A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDSin hoidossa
GEP20012446B (en) Inhibitors of Interleukin- 1β Converting Enzyme
DK0489837T3 (da) Inhibering af lymfocytters adhæsion til vaskulært endotel under anvendelse af en hidtil ukendt interaktion mellem ekstracellulær matrixreceptor og ligand
DE69837295D1 (de) Probucolbernsteinsäureester zur Hemmung der Expression von VCAM-1
EP0393445A3 (de) Verwendung von renininhibitorischen Peptiden als Mittel gegen Retroviren
AP9100310A0 (en) Tnf inhibitors
AU636148B2 (en) Human leukocyte elastase inhibitors
NO934218D0 (no) Inhibitorer av cathepsin G og elastase for forhindring avbindevevsnedbrytning
FI935777L (fi) AIDSin hoitamisessa käyttökelpoiset HIV-proteaasin inhibiittorit
FR2643557B1 (fr) Utilisation de n-acylcysteines dans le traitement de maladies associees aux infections par hiv
KR880700671A (ko) 포유동물에서 상피창상의 치유향상방법
FI946202A7 (fi) Fluoria sisältäviä dipeptidejä inhibiittoreina ihmisen lenkosyyttielas taasi-inhibiittoreita vastaan
MX9302750A (es) Nuevos inhibidores de neutrofilos y proceso para su preparacion.
EP0396709A4 (en) Human leukocyte elastase inhibitors and methods of producing and using same
DE69325899D1 (de) 3-ALKYLOXY-, ARYLOXY-, ODER ARYLALKYLOXY- BENZO[b]THIOPHEN- 2-CARBOXAMIDE ALS INHIBITOREN VON ZELLADHÄSION
BG50035A3 (bg) Метод за получаване на човешки левкоцити и гама-интерферони
CA2017315A1 (en) Interleukin i inhibitor
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee